Q2 2023 Earnings Presentation

Solid balance sheet Operating Cash Flow ($M) Capital Expenditures ($M) Free Cash Flow ($M) $883.9 $787.9 Total debt outstanding $1,801M Less: Cash & cash equiv. $253M Net Debt $1,547M İ $577.0 $465.0 $133.5 $370.2 $112.0 $96.0 $236.7 Unused borrowing capacity $390M LTM 2Q21 LTM 2Q22 LTM 2Q23 LTM 2Q21 LTM 2Q22 LTM 2Q23 LTM 2Q21 LTM 2Q22 LTM 2Q23 Expect liquidity to improve as supply chain environment improves and inventory levels come down 9 2023 ResMed | Q2 2023 Earnings Presentation - Jan. 26, 2023 ResMed

View entire presentation